Phillip Ecker, MD
Dermatology · Wayzata, MNNPI 1851378020
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $25,738 of the $31,292 with a category attached, or 82.3%. Lilly USA, LLC accounts for 73.7% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $24,829 and has fallen 99.8% since, to $61 in 2025. Among dermatology clinicians in MN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 86 payments — averaging $363.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$23K
- Sun Pharmaceutical Industries Inc.$7K
- Johnson & Johnson$842
- Sanofi$106
- Amgen$78
- Regeneron Healthcare Solutions, Inc.$77
- plus $447 from 18 others
What the payments were for
- Consulting fees$3,68812%
- Speaking & faculty fees$25,73882%
- Travel & lodging$8873%
- Food & beverage$9803%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 32 | $23,071 |
| Sun Pharmaceutical Industries Inc. | 8 | $6,671 |
| Johnson & Johnson | 4 | $842 |
| Sanofi | 6 | $106 |
| Amgen | 5 | $78 |
| Regeneron Healthcare Solutions, Inc. | 4 | $77 |
| UCB, Inc. | 3 | $67 |
| Novartis | 3 | $45 |
| AbbVie | 3 | $44 |
| Biofrontera Inc. | 2 | $36 |
| Pfizer | 2 | $26 |
| E.r. Squibb & Sons, L.L.C. | 1 | $25 |
| Mallinckrodt Enterprises LLC | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Sensus Healthcare, Inc. | 1 | $21 |
| Strata Skin Sciences, Inc. | 2 | $21 |
| GSK | 1 | $20 |
| Genentech USA, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $13 |
| Dermira, Inc. | 1 | $13 |
| Promius Pharma LLC | 1 | $12 |
| Kerecis Limited | 1 | $12 |
| LEO Pharma Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$31,292 in reported general payments places this provider in the 95th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $40,602 |
| Ketoconazole | 375 | $7,807 |
| Clobetasol Propionate | 165 | $6,899 |
| Metronidazole | 56 | $3,157 |
| Triamcinolone Acetonide | 171 | $2,540 |
| MethotrexateMethotrexate Sodium | 57 | $1,739 |
| Hydrocortisone | 216 | $1,703 |
| Tacrolimus | 16 | $1,649 |
| Azelaic Acid | 15 | $1,513 |
| ValacyclovirValacyclovir Hcl | 24 | $552 |
| Mupirocin | 39 | $518 |
| Minoxidil | 37 | $489 |
| Doxycycline Monohydrate | 27 | $435 |
| Spironolactone | 16 | $432 |
| Cephalexin | 86 | $411 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Wayzata
- Mary MeighanWayzata$1K
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
- Noah GoldfarbMinneapolis$30K
- Saranya WylesRochester$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.